Concepedia

Lukas Leiendecker

LL

Statistics

Publications

4

Citations

367

H-Index

4

Active since

2019

Affiliations

Institute of Molecular Biotechnology(Current)

Medical University of Vienna

Research Institute of Molecular Pathology

Vienna Biocenter

Lukas Leiendecker is an author at Institute of Molecular Biotechnology specializing in medicine, molecular oncology, and cancer molecular pathology.

Publications per year

2019–2022

4

Publications

4

Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma

Lisa Haas, Anais Elewaut, Camille L. Gérard et al. · Nature Cancer · 2021 · 196 citations · Full text

Medicine, Immunology, Oncology +14

Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers

Lukas Leiendecker, Tobias Neumann, Pauline S. Jung et al. · Cancer Discovery · 2022 · 63 citations · Full text

Medicine, Molecular Biology, Oncology +17

LSD1 inhibition induces differentiation and cell death in Merkel cell carcinoma

Lukas Leiendecker, Pauline S. Jung, Izabela Kręcioch et al. · EMBO Molecular Medicine · 2020 · 62 citations · Full text

Medicine, Dermatology, Pathology +16

Dual Role of Ribosome-Binding Domain of NAC as a Potent Suppressor of Protein Aggregation and Aging-Related Proteinopathies

Koning Shen, Martin Gamerdinger, Rebecca J. Chan et al. · Molecular Cell · 2019 · 46 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +11

1–4 of 4